Dr. Bai’s research interests lie in development and refinement of bioinformatics algorithms/software and databases on next-generation sequencing (NGS data), development of statistical model for solving biological problems, bioinformatics analysis of clinical data, as well as other topics including, but not limited to, uncovering disease genes and variants using informatics approaches, computational analysis of cis-regulation and comparative motif finding, large-scale genome annotation, comparative “omics”, and evolutionary genomics.
Dr. Veera Baladandayuthapani is currently a Professor in the Department of Biostatistics at University of Michigan (UM), where he is also the Associate Director of the Center for Cancer Biostatistics. He joined UM in Fall 2018 after spending 13 years in the Department of Biostatistics at University of Texas MD Anderson Cancer Center, Houston, Texas, where was a Professor and Institute Faculty Scholar and held adjunct appointments at Rice University, Texas A&M University and UT School of Public Health. His research interests are mainly in high-dimensional data modeling and Bayesian inference. This includes functional data analyses, Bayesian graphical models, Bayesian semi-/non-parametric models and Bayesian machine learning. These methods are motivated by large and complex datasets (a.k.a. Big Data) such as high-throughput genomics, epigenomics, transcriptomics and proteomics as well as high-resolution neuro- and cancer- imaging. His work has been published in top statistical/biostatistical/bioinformatics and biomedical/oncology journals. He has also co-authored a book on Bayesian analysis of gene expression data. He currently holds multiple PI-level grants from NIH and NSF to develop innovative and advanced biostatistical and bioinformatics methods for big datasets in oncology. He has also served as the Director of the Biostatistics and Bioinformatics Cores for the Specialized Programs of Research Excellence (SPOREs) in Multiple Myeloma and Lung Cancer and Biostatistics&Bioinformatics platform leader for the Myeloma and Melanoma Moonshot Programs at MD Anderson. He is a fellow of the American Statistical Association and an elected member of the International Statistical Institute. He currently serves as an Associate Editor for Journal of American Statistical Association, Biometrics and Sankhya.
The future of transportation lies at the intersection of two emerging trends, namely, the sharing economy and connected and automated vehicle technology. Our research group investigates the impact of these two major trends on the future of mobility, quantifying the benefits and identifying the challenges of integrating these technologies into our current systems.
Our research on shared-use mobility systems focuses on peer-to-peer (P2P) ridesharing and multi-modal transportation. We provide: (i) operational tools and decision support systems for shared-use mobility in legacy as well as connected and automated transportation systems. This line of research focuses on system design as well as routing, scheduling, and pricing mechanisms to serve on-demand transportation requests; (ii) insights for regulators and policy makers on mobility benefits of multi-modal transportation; (ii) planning tools that would allow for informed regulations of sharing economy.
In another line of research we investigate challenges faced by the connected automated vehicle technology before mass adoption of this technology can occur. Our research mainly focuses on (i) transition of control authority between the human driver and the autonomous entity in semi-autonomous (level 3 SAE autonomy) vehicles; (ii) incorporating network-level information supplied by connected vehicle technology into traditional trajectory planning; (iii) improving vehicle localization by taking advantage of opportunities provided by connected vehicles; and (iv) cybersecurity challenges in connected and automated systems. We seek to quantify the mobility and safety implications of this disruptive technology, and provide insights that can allow for informed regulations.
My research is focused on developing efficient and effective statistical and computational methods for genetic and genomic studies. These studies often involve large-scale and high-dimensional data; examples include genome-wide association studies, epigenome-wide association studies, and various functional genomic sequencing studies such as bulk and single cell RNAseq, bisulfite sequencing, ChIPseq, ATACseq etc. Our method development is often application oriented and specifically targeted for practical applications of these large-scale genetic and genomic studies, thus is not restricted in a particular methodology area. Our previous and current methods include, but are not limited to, Bayesian methods, mixed effects models, factor analysis models, sparse regression models, deep learning algorithms, clustering algorithms, integrative methods, spatial statistics, and efficient computational algorithms. By developing novel analytic methods, I seek to extract important information from these data and to advance our understanding of the genetic basis of phenotypic variation for various human diseases and disease related quantitative traits.
Dr. Lee’s research in data science concerns biological questions in systems biology and network medicine by developing algorithms and models through a combination of statistical/machine learning, information theory, and network theory applied to multi-dimensional large-scale data. His projects have covered genomics, transcriptomics, proteomics, and metabolomics from yeast to mouse to human for integrative analysis of regulatory networks on multiple molecular levels, which also incorporates large-scale public databases such as GO for functional annotation, PDB for molecular structures, and PubChem and LINCS for drugs or small compounds. He previously carried out proteomics and metabolomics along with a computational derivation of dynamic protein complexes for IL-3 activation and cell cycle in murine pro-B cells (Lee et al., Cell Reports 2017), for which he developed integrative analytical tools using diverse approaches from machine learning and network theory. His ongoing interests in methodology include machine/deep learning and topological Kolmogorov-Sinai entropy-based network theory, which are applied to (1) multi-level dynamic regulatory networks in immune response, cell cycle, and cancer metabolism and (2) mass spectrometry-based omics data analysis.
Samuel K Handelman, Ph.D., is Research Assistant Professor in the department of Internal Medicine, Gastroenterology, of Michigan Medicine at the University of Michigan, Ann Arbor. Prof. Handelman is focused on multi-omics approaches to drive precision/personalized-therapy and to predict population-level differences in the effectiveness of interventions. He tends to favor regression-style and hierarchical-clustering approaches, partially because he has a background in both statistics and in cladistics. His scientific monomania is for compensatory mechanisms and trade-offs in evolution, but he has a principled reason to focus on translational medicine: real understanding of these mechanisms goes all the way into the clinic. Anything less that clinical translation indicates that we don’t understand what drove the genetics of human populations.
Jinseok Kim, Ph.D., is Research Assistant Professor in the Institute for Social Research at the University of Michigan, Ann Arbor. Prof. Kim works on resolving named entity ambiguity in large-scale scholarly data (publication, patent, and funding records) in digital libraries. Especially, his current research is focused on developing methods for disambiguating author and affiliation names at a digital library scale using various supervised machine learning approaches trained on automatically labeled data . Disambiguated data from multiple sources will be integrated to be analyzed for insights into research production, scientific collaboration, funding evaluation, and research policy at a national level.
My research focus is on the development and application of machine learning tools to large scale financial and unstructured (textual) data to extract, quantify and predict risk profiles and investment grade rating of private and public companies. Example datasets include social media and financial aggregators such as Bloomberg, Pitchbook, and Privco.
Jon Zelner, PhD, is Assistant Professor in the department of Epidemiology in the University of Michigan School of Public Health. Dr. Zelner holds a second appointment in the Center for Social Epidemiology and Population Health.
Dr. Zelner’s research is focused on using spatial analysis, social network analyisis and dynamic modeling to prevent infectious diseases, with a focus on tuberculosis and diarrheal disease. Jon is also interested in understanding how the social and biological causes of illness interact to generate observable patterns of disease in space and in social networks, across outcomes ranging from infection to mental illness.